Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Garver

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Psychopharmacology|January 1, 1983
Clinical response and plasma haloperidol levels in schizophreniaM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Journal of Clinical Psychopharmacology|December 1, 1983
Thioridazine effect on desipramine plasma levelsJ Hirschowitz, J A Bennett, F P Zemlan, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1984
Impact of lithium therapy on core psychotic symptoms of schizophreniaF P Zemlan, J Hirschowitz, F J Sautter, et al.
The American Journal of Psychiatry|October 1, 1995
Predictors of response to lithium in patients with psychosesL W Schexnayder, J Hirschowitz, F J Sautter, et al.
Journal of Clinical Psychopharmacology|June 1, 1984
Clinical relevance of thiothixene plasma levelsM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Schizophrenia Bulletin|January 1, 1989
Schizophrenia and the question of genetic heterogeneityD L Garver, T Reich, K E Isenberg, et al.
The American Journal of Psychiatry|November 1, 1975
Growth hormone catecholamines in affective diseaseD L Garver, G N Pandey, H Dekirmenjian, et al.
Schizophrenia Research|November 14, 2001
Schizophrenia spectrum disorders: an autosomal-wide scan in multiplex pedigreesD L Garver, J Holcomb, F M Mapua, et al.
The American Journal of Psychiatry|May 1, 1979
Beta-adrenergic receptor function in affective illnessG N Pandey, M W Dysken, D L Garver, et al.
Archives of General Psychiatry|March 1, 1980
Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophreniaR Casper, D L Garver, H Dekirmenjian, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Psychopharmacology|January 1, 1983
Clinical response and plasma haloperidol levels in schizophreniaM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Journal of Clinical Psychopharmacology|December 1, 1983
Thioridazine effect on desipramine plasma levelsJ Hirschowitz, J A Bennett, F P Zemlan, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1984
Impact of lithium therapy on core psychotic symptoms of schizophreniaF P Zemlan, J Hirschowitz, F J Sautter, et al.
The American Journal of Psychiatry|October 1, 1995
Predictors of response to lithium in patients with psychosesL W Schexnayder, J Hirschowitz, F J Sautter, et al.
Journal of Clinical Psychopharmacology|June 1, 1984
Clinical relevance of thiothixene plasma levelsM L Mavroidis, D R Kanter, J Hirschowitz, et al.
Schizophrenia Bulletin|January 1, 1989
Schizophrenia and the question of genetic heterogeneityD L Garver, T Reich, K E Isenberg, et al.
The American Journal of Psychiatry|November 1, 1975
Growth hormone catecholamines in affective diseaseD L Garver, G N Pandey, H Dekirmenjian, et al.
Schizophrenia Research|November 14, 2001
Schizophrenia spectrum disorders: an autosomal-wide scan in multiplex pedigreesD L Garver, J Holcomb, F M Mapua, et al.
The American Journal of Psychiatry|May 1, 1979
Beta-adrenergic receptor function in affective illnessG N Pandey, M W Dysken, D L Garver, et al.
Archives of General Psychiatry|March 1, 1980
Phenothiazine levels in plasma and red blood cells. Their relationship to clinical improvement in schizophreniaR Casper, D L Garver, H Dekirmenjian, et al.
Pageof 10